Iviva Medical

‐ Iviva Medical ‐ Iviva Medical ‐

IVIVA is a spin-out from the Harvard Stem Cell Institute addressing the chronic shortage of organs available for transplant. IVIVA’s proprietary 3D printing technology is capable of biofabricating vascularized organ seeded with human cells across a broad range of organs, reducing risk of organ rejection.

Visit Company Website

Brock Reeve CEO

Technologies

Advanced Manufacturing,

Biotechnology,

Computational Biology

Stealth Therapeutics Company